Literature DB >> 24357012

Capsule commentary on Michaelidis et al., Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults.

Mary Lynn Davis-Ajami1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24357012      PMCID: PMC3965753          DOI: 10.1007/s11606-013-2735-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

1.  Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

Authors:  Hans-Georg Eichler; Sheldon X Kong; William C Gerth; Panagiotis Mavros; Bengt Jönsson
Journal:  Value Health       Date:  2004 Sep-Oct       Impact factor: 5.725

Review 2.  Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation.

Authors:  Daren K Heyland; Ana P Johnson; Steven C Reynolds; John Muscedere
Journal:  Crit Care Med       Date:  2011-07       Impact factor: 7.598

Review 3.  Role of procalcitonin in managing adult patients with respiratory tract infections.

Authors:  Philipp Schuetz; Devendra N Amin; Jeffrey L Greenwald
Journal:  Chest       Date:  2012-04       Impact factor: 9.410

4.  Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults.

Authors:  Constantinos I Michaelidis; Richard K Zimmerman; Mary Patricia Nowalk; Michael J Fine; Kenneth J Smith
Journal:  J Gen Intern Med       Date:  2014-04       Impact factor: 5.128

5.  Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia.

Authors:  Kenneth J Smith; Angela Wateska; M Patricia Nowalk; Mahlon Raymund; Bruce Y Lee; Richard K Zimmerman; Michael J Fine
Journal:  J Gen Intern Med       Date:  2013-09       Impact factor: 5.128

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.